Immunoreactive glycoprotein gp19 of ehrlichia canis

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/31 (2006.01) A61K 39/02 (2006.01) A61P 31/04 (2006.01) C07K 14/29 (2006.01) C07K 16/12 (2006.01) G01N 33/569 (2006.01)

Patent

CA 2662246

The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.

L'invention concerne des compositions immunoréactives gp19 pour l'E. canis, et des compositions apparentées à celles-ci, comprenant les vaccins, les anticorps, les polypeptides, les peptides, et les polynucléotides. En particulier, on décrit des épitopes pour l'E. canis gp19.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunoreactive glycoprotein gp19 of ehrlichia canis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunoreactive glycoprotein gp19 of ehrlichia canis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoreactive glycoprotein gp19 of ehrlichia canis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1932598

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.